21.04.2020 Views

Annual-Report-2019

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ARD 2020

BIOPHARMACEUTICALS

A drug is any substance or composition presented as having properties for treating,

preventing or diagnosing disease in humans or animals whereas BIOPHARMACEUTICALS

in the strict sense of the term, are molecules that have the characteristic of being

produced from living organisms or their cellular components. These molecules are

intermediate between chemical drugs and organisms’ intrinsic biologics. The proportion

of biopharmaceuticals in the drug market is constantly increasing and represents about

30% of the market. The Centre-Val de Loire region is at the cutting edge of research in

the pharmaceutical sector and has included the development of biopharmaceuticals

into its smart specialisation strategy. The Regional Council supports research in this

sector to facilitate innovative industrial development and partnerships for socioeconomic

development beyond 2020. The ARD 2020 Biopharmaceuticals programme aims to further

develop and strengthen the Centre- Val de Loire region biopharmaceuticals industry by

capitalising on the recognised capabilities of the multidisciplinary research teams from the

regional research institutions so as to:

Develop a flagship research and development pole on biopharmaceuticals in

the Centre-Val de Loire region.

Configure the biopharmaceuticals field by inter-sectorial development and

innovation in the pharmacy/health sectors through start-ups, SMEs (Small

and Medium Enterprises) including established local and regional based

multinational companies.

Promote the transfer of technologies/competences to existing and new

businesses.

Support the development of new competences for the sector.

The Biopharmaceuticals Programme focuses on the design and biosynthesis of

biomolecules for preclinical and clinical development by including the search for synergies

with conventional chemically synthesised drugs. The programme involves working with

a wide spectrum of biological molecules (vaccines, therapeutic antibodies, nucleic acids,

lipoproteins...) with the need for a diverse range of competences and the involvement of

teams with complementary expertise.

The researchers present in the region Centre-Val de Loire, working in the disciplines of life

sciences, are invited to participate and work in synergy, for inter-sectorial development and

innovation, in the pharmacy/health sectors to deliver socioeconomic outcomes.

ARD 2020 Programme 2019

13

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!